Immunovant, Inc. (IMVT)
31.14
-0.47
(-1.49%)
USD |
NASDAQ |
Jun 10, 15:11
Immunovant Total Assets (Quarterly) : 957.57M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Roivant Sciences Ltd. | 5.728B |
| Summit Therapeutics, Inc. | 647.86M |
| Protagonist Therapeutics, Inc. | 697.46M |
| UroGen Pharma Ltd. | 253.69M |
| Cogent Biosciences, Inc. | 903.01M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 104.98M |
| Shareholders Equity (Quarterly) | 852.59M |
| Debt to Equity Ratio | 0.0001 |
| Current Ratio | 9.086 |
| Net Debt Paydown Yield | -0.00% |